GAROSI, GUIDO
 Distribuzione geografica
Continente #
EU - Europa 3.698
NA - Nord America 3.453
AS - Asia 2.335
SA - Sud America 378
AF - Africa 165
OC - Oceania 10
Totale 10.039
Nazione #
US - Stati Uniti d'America 3.387
RU - Federazione Russa 924
IT - Italia 770
CN - Cina 768
SG - Singapore 705
IE - Irlanda 542
GB - Regno Unito 524
BR - Brasile 314
VN - Vietnam 237
SE - Svezia 200
FR - Francia 192
HK - Hong Kong 190
DE - Germania 182
KR - Corea 176
UA - Ucraina 108
FI - Finlandia 90
ZA - Sudafrica 89
IN - India 85
ES - Italia 35
BD - Bangladesh 30
CA - Canada 29
TR - Turchia 28
PL - Polonia 24
RO - Romania 23
MA - Marocco 22
MX - Messico 21
AR - Argentina 20
NL - Olanda 20
IQ - Iraq 19
JP - Giappone 16
CI - Costa d'Avorio 14
AT - Austria 13
KE - Kenya 13
PK - Pakistan 12
BE - Belgio 10
AU - Australia 9
CL - Cile 8
CO - Colombia 8
EC - Ecuador 8
IR - Iran 8
SA - Arabia Saudita 7
SI - Slovenia 7
ID - Indonesia 6
TN - Tunisia 6
VE - Venezuela 6
CH - Svizzera 5
JM - Giamaica 5
MY - Malesia 5
SN - Senegal 5
CR - Costa Rica 4
JO - Giordania 4
KG - Kirghizistan 4
KZ - Kazakistan 4
NG - Nigeria 4
NP - Nepal 4
PE - Perù 4
UY - Uruguay 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
AO - Angola 3
AZ - Azerbaigian 3
ET - Etiopia 3
HR - Croazia 3
LV - Lettonia 3
OM - Oman 3
PH - Filippine 3
PY - Paraguay 3
BG - Bulgaria 2
BO - Bolivia 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EG - Egitto 2
GE - Georgia 2
IL - Israele 2
LT - Lituania 2
NO - Norvegia 2
PT - Portogallo 2
RS - Serbia 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
BH - Bahrain 1
BJ - Benin 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
DZ - Algeria 1
EE - Estonia 1
GD - Grenada 1
GM - Gambi 1
GR - Grecia 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
IM - Isola di Man 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
Totale 10.033
Città #
Dublin 539
Dallas 473
Southend 418
Singapore 388
Chandler 294
Ashburn 269
Moscow 259
Hefei 251
Santa Clara 237
Fairfield 196
Hong Kong 181
Seoul 175
Siena 171
Beijing 165
San Jose 146
Woodbridge 98
Ann Arbor 89
Jacksonville 85
Seattle 85
Johannesburg 84
Ho Chi Minh City 80
Cambridge 76
Los Angeles 74
Houston 70
Wilmington 68
Milan 67
The Dalles 64
Menlo Park 58
Florence 57
Lauterbourg 57
New York 56
Hanoi 52
Helsinki 46
Boardman 44
Princeton 39
Bengaluru 38
Munich 37
Nanjing 35
Council Bluffs 34
São Paulo 28
Rome 27
Orem 26
Buffalo 24
Shanghai 24
Redondo Beach 22
Dearborn 21
Frankfurt am Main 20
Turku 20
Warsaw 19
San Diego 18
San Mateo 18
Messina 17
Stockholm 16
Washington 16
Abidjan 14
Brooklyn 14
Iesi 14
Izmir 14
London 14
Nuremberg 14
Montreal 13
Málaga 13
Rio de Janeiro 13
Tianjin 13
Tokyo 13
Chicago 12
Amsterdam 11
Chennai 11
Denver 11
Casablanca 10
Da Nang 10
Marrakesh 10
Casalecchio di Reno 9
Lappeenranta 9
Phoenix 9
Poplar 9
Prato 9
Toronto 9
Bologna 8
Brussels 8
Columbus 8
Hillsboro 8
Brescia 7
Dong Ket 7
Haiphong 7
Istanbul 7
Ljubljana 7
Madrid 7
Mumbai 7
Paris 7
San Francisco 7
Saronno 7
Vienna 7
Baghdad 6
Boston 6
Brasília 6
Changsha 6
Codogno 6
Curitiba 6
Falkenstein 6
Totale 6.400
Nome #
null 398
ANDAMENTO LONGITUDINALE DI BIOMARKERS DI INFIAMMAZIONE ED IMMUNOATTIVAZIONE IN PAZIENTI SOTTOPOSTI A TRAPIANTO DI RENE: UN RUOLO DELLA REPLICAZIONE DI CMV? 345
Alport syndrome: impact of digenic inheritance in patients management 305
HCMV infection in renal transplant recipients: a retrospective cohort study 279
Clinical and MRI improvement in a case of progressive multifocal leukoencephalopathy 271
Advances in Alport syndrome diagnosis using next-generation sequencing 260
Everolimus in kidney transplant recipients at high cardiovascular risk: a narrative review 255
Diagnostic accuracy of anti-phospholipase A2 receptor (PLA2R) antibodies in idiopathic membranous nephropathy: an Italian experience 249
Epidemiologic study of neonatal jaundice. A survey of contributing factors 241
Expert consensus guidelines for the genetic diagnosis of Alport syndrome 221
Ozonation of blood during extracorporeal circulation. I. Rationale, methodology and preliminary studies 218
Detection of cryptic mosaicism in X-linked alport syndrome prompts to re-evaluate living-donor kidney transplantation 218
SARS-CoV-2 in pleural fluid in a kidney transplant patient 213
Deep Learning Approaches for the Segmentation of Glomeruli in Kidney Histopathological Images 207
Studies for the evaluation of oxygenation and ozonation of blood during extracorporeal circulation 189
Base genetica della microangiopatia trombotica post-trapianto di midollo: l’ultimo tassello del puzzle? [The genetic basis of post-bone marrow transplant thrombotic microangiopathy: is this the last piece of the puzzle?] 187
Brief Communication PD1-related Nephrotoxicity: Optimizing Its Clinical Management Through Histopathologic Features 184
Slowly progressive autosomal dominant Alport Syndrome due to COL4A3 splicing variant 183
null 182
Livedo racemosa and hemolytic uremic syndrome induced by gemcitabine 178
Rationale for the evaluation of renal functional reserve in allogeneic stem cell transplantation candidates: a pilot study 176
Letter to the Editor: Kidney Transplantation and Obesity are There Any Differences in Outcomes? 173
Unusual presentation of secondary syphilis: membranoproliferative glomerulonephritis andmuco-cutaneous lesions 172
Il ruolo dell'infezione da CMV e del suo monitoraggio attivo nella nuova era dei trapianti di rene: risultati di una coorte completa 170
Diagnosis, treatment, and follow-up of patients with cerebral amyloid angiopathy-related inflammation 165
Purtscher-like retinopathy in a patient with systemic tacrolimus vasculopathy 160
Minimal change disease following vaccination for SARS-CoV-2 153
Transcriptomic analysis after SARS-CoV-2 mRNA vaccination reveals a specific gene signature in low-responder hemodialysis patients 153
Evaluation of renal functional reserve with oral protein load or new ultrasound test 150
Excellent long-term results in de novo renal transplant recipients treated with proliferation signal inhibitors and reduced calcineurin inhibitors exposure. 148
Longitudinal immunogenicity cohort study of SARS-CoV-2 mRNA vaccines across individuals with different immunocompromising conditions: heterogeneity in the immune response and crucial role of Omicron-adapted booster doses 145
Excellent long term results in de-novo renal transplant recipients treated with m-TOR inhibitors, basiliximab and reduced calcineurin inhibitors exposure 138
THE EVALUATION OF RENAL FUNCTIONAL RESERVE WITH ORAL PROTEIN LOAD OR ULTRASOUND TEST: A REAL-LIFE PERSPECTIVE 136
Biocompatibility of a peritoneal dialysis solution with amino acids: Histological evaluation in the rabbit 136
A new self-locating peritoneal catheter 134
Kidney vascular damage and cocaine 129
Atlas of Peritoneal Histology 125
Dalla Mailing-List soci SIN (ML-SIN): la sclerosi peritoneale [From the Mailing List SIN: peritoneal sclerosis] 120
Primo Case Report di utilizzo dell’Ofatumumab nel trapianto renale AB0 incompatibile [First case report of using Ofatumumab in kidney transplantation AB0 incompatible] 120
Dalla Mailing-List soci SIN (ML-SIN). La sclerosi peritoneale: terapia e prevenzione [From the Mailing List SIN: Therapy and prevention of peritoneal sclerosis] 117
Urine-derived podocytes-lineage cells: A promising tool for precision medicine in Alport Syndrome 114
Clinical effects of biocompatible dialysis fluids 111
Different Aspects of Peritoneal Damage: Fibrosis and Sclerosis 110
Risk factors and action thresholds for the novel coronavirus pandemic. Insights from the Italian Society of Nephrology COVID-19 Survey 110
Dialisi peritoneale: metodica a termine a causa della peritonite sclerosante? No, ma ci sono approcci migliori. [Peritoneal dialysis: a time-limited therapy because of encapsulating peritoneal sclerosis? No, but better approaches are available] 110
Videothoracoscopic obliteration of pleuroperitoneal fistula in continuous peritoneal dialysis 110
Alport syndrome: a unified classification of genetic disorders of collagen IV α345: a position paper of the Alport Syndrome Classification Working Group 109
Using Renal Elastography to Predict the Therapeutic Response of Nephrological Patients 109
A collaborative approach to understanding EPS: The European perspective 107
Encapsulating peritoneal sclerosis 102
Immunodeficiency-related high-grade B-cell lymphoma with 11q aberration: Further evidence for a lymphoma entity from a patient with simultaneous papillary renal cell carcinoma following pediatric kidney transplant 101
Health-Related Quality of Life in pre-dialysis patients with chronic kidney disease: the role of Big-Five personality traits and illness denial 97
Sclerosing peritonitis: A nosological entity 95
Early Conversion From Calcineurin Inhibitor- to Everolimus-Based Therapy Following Kidney Transplantation: Results of the Randomized ELEVATE Trial 94
Simple peritoneal sclerosis and sclerosing peritonitis: related or distinct entities? 86
Omental milky spots and peritoneal dialysis - Review and personal experience 84
RENAL FUNCTIONAL RESERVE AS A MARKER TO STRATIFY THE RISK OF KIDNEY INJURY IN HEMATOPOIETIC STEM CELL TRANSPLANTATION 84
Mesothelial biocompatibility of peritoneal dialysis solutions 81
The social cost of chronic kidney disease in Italy 80
Morphological aspects of peritoneal sclerosis 78
The peritoneal dialysis catheter 76
Peritoneal sclerosis: One or two nosological entities? 76
The rabbit model in evaluating the biocompatibility in peritoneal dialysis 76
Effetto del naloxone e del naltrexone sulla spesa energetica post-prandiale e sulla risposta del pancreas endocrino ad un pasto misto nell'obesita essenziale. [Effect of naloxone and naltrexone on the postprandial energy expenditure and endocrine pancreas response to a mixed meal in essential obesity] 72
No need for an "expiry date" in chronic peritoneal dialysis to prevent encapsulating peritoneal sclerosis 62
Encapsulating Peritoneal Sclerosis - Comment on the 8th GPDP-SIN 2022 Census data 61
Histological and clinical findings in patients with post-transplantation and classical encapsulating peritoneal sclerosis: a European multicenter study 37
null 31
null 2
null 1
Totale 10.169
Categoria #
all - tutte 32.744
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.744


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021171 0 0 0 0 0 0 0 0 0 62 55 54
2021/2022427 38 54 26 46 12 17 14 17 23 40 46 94
2022/20231.049 25 66 123 138 117 234 30 98 120 24 54 20
2023/2024884 25 19 55 36 46 228 282 41 16 17 14 105
2024/20251.836 26 72 146 78 230 135 60 86 169 77 178 579
2025/20263.982 391 654 375 562 872 170 506 138 109 205 0 0
Totale 10.169